Hims Hers Health is trading 4.93% down at $30.10 on August 28, 2026, with no clearly attributable catalyst identified for the decline.
- The move reverses the prior session’s 6.13% gain.
- Recent pressure has centered on Visa-related payment disputes and ongoing regulatory and margin concerns, though coverage does not directly link them to today’s decline.
- Broader markets are modestly higher; delayed news should be rechecked.